Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129


Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis.

Foley N, Pereira S, Salter K, Fernandez MM, Speechley M, Sequeira K, Miller T, Teasell R.

Arch Phys Med Rehabil. 2013 May;94(5):977-89. doi: 10.1016/j.apmr.2012.12.006. Epub 2012 Dec 19. Review.


BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.


Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.

Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.

Arch Phys Med Rehabil. 2008 May;89(5):799-806. doi: 10.1016/j.apmr.2008.01.007.


Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.

Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A.

Arq Neuropsiquiatr. 2005 Mar;63(1):30-3. Epub 2005 Apr 13.


Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.

Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.

Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.


Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.

Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL.

Neurorehabil Neural Repair. 2010 Jan;24(1):34-41. doi: 10.1177/1545968309341060. Epub 2009 Sep 3.


Further assessment to determine the additive effect of botulinum toxin type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability.

Wolf SL, Milton SB, Reiss A, Easley KA, Shenvi NV, Clark PC.

Arch Phys Med Rehabil. 2012 Apr;93(4):578-87. doi: 10.1016/j.apmr.2011.10.026. Epub 2011 Dec 27.


Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.

Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox Post-Stroke Spasticity Study Group.

N Engl J Med. 2002 Aug 8;347(6):395-400.


Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.

Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM.

Am J Phys Med Rehabil. 2012 Dec;91(12):1007-19. doi: 10.1097/PHM.0b013e31826ecb02.


A meta-analysis of botulinum toxin sphincteric injections in the treatment of incomplete voiding after spinal cord injury.

Mehta S, Hill D, Foley N, Hsieh J, Ethans K, Potter P, Baverstock R, Teasell RW, Wolfe D; Spinal Cord Injury Rehabilitation Evidence Research Team.

Arch Phys Med Rehabil. 2012 Apr;93(4):597-603. doi: 10.1016/j.apmr.2011.11.020. Epub 2012 Feb 24. Review.


Feasibility of video clip analysis on effect of botulinum toxin-A injection for post-stroke upper limb spasticity.

Kim WJ, Kumthornthip W, Oh BM, Yang EJ, Paik NJ.

Toxins (Basel). 2013 May 10;5(5):983-91. doi: 10.3390/toxins5050983.


Botulinum toxin type A in post-stroke upper limb spasticity.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group.

Curr Med Res Opin. 2010 Aug;26(8):1983-92. doi: 10.1185/03007995.2010.497103.


Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.

Albani G, Cimolin V, Galli M, Vimercati S, Bar D, Campanelli L, Gandolfi R, Lombardi R, Mauro A.

Funct Neurol. 2010 Apr-Jun;25(2):103-7.


Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.

McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.

J Rehabil Med. 2009 Jun;41(7):536-44. doi: 10.2340/16501977-0366.


Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.

Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.

J Rehabil Med. 2011 Nov;43(11):1032-7. doi: 10.2340/16501977-0885.


Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?

Nott MT, Barden HL, Baguley IJ.

J Rehabil Med. 2014 Oct;46(9):864-8. doi: 10.2340/16501977-1853.


Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.

Turkel CC, Bowen B, Liu J, Brin MF.

Arch Phys Med Rehabil. 2006 Jun;87(6):786-92.


Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.

Jahangir AW, Tan HJ, Norlinah MI, Nafisah WY, Ramesh S, Hamidon BB, Raymond AA.

Med J Malaysia. 2007 Oct;62(4):319-22.


Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.

Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.

PLoS One. 2015 Jun 1;10(6):e0128633. doi: 10.1371/journal.pone.0128633. eCollection 2015.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk